Insmed
INSM
238 hedge funds and large institutions have $2.74B invested in Insmed in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 93 increasing their positions, 60 reducing their positions, and 20 closing their positions.
125% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 20
55% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 60
37% more call options, than puts
Call options by funds: $6.73M | Put options by funds: $4.93M
11% more funds holding
Funds holding: 214 → 238 (+24)
7% more capital invested
Capital invested by funds: $2.55B → $2.74B (+$191M)
2.09% less ownership
Funds ownership: 108.1% → 106.01% (-2.1%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$18.2M |
| 2 |
Millennium Management
New York
|
+$16.3M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$12M |
| 4 |
Bank of New York Mellon
New York
|
+$10.6M |
| 5 |
Goldman Sachs
New York
|
+$9.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$160M |
| 2 |
Janus Henderson Group
London,
|
-$85.8M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$51.2M |
| 4 |
Holocene Advisors
New York
|
-$27.9M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$25.4M |
INSM Hedge Fund Activity: Q3 2022 in Review
238 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2022, worth a combined $2.74B — up 7.5% from $2.55B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new INSM positions and 20 closed out — a net gain of 25 holders — while 93 added to existing stakes and 60 trimmed.
The largest buyer was Polar Capital Holdings, adding an estimated $18.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $160M.
- 238 institutional investors held Insmed (INSM) as of Q3 2022, up from 214 in Q2 2022.
- Funds reported $2.74B of Insmed stock for Q3 2022, up 7.5% quarter-over-quarter.
- 45 funds opened new Insmed positions in Q3 2022 and 20 closed out, a net change of +25 holders.
- The largest Insmed buyer in Q3 2022 was Polar Capital Holdings, an estimated $18.2M added.
- The largest Insmed seller in Q3 2022 was T. Rowe Price Associates, an estimated $160M sold.
Based on aggregated 13F filings for Q3 2022.